Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
ESMO Open
|
July 16, 2025
A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients
E A Martino, G Caridà, D Lofaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2008
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma
A Palumbo, F Gay, S Bringhen, et al.
Pathologica
|
March 8, 2012
Primary synovial sarcoma of the kidney. A case report with pathologic appraisal investigation and literature review
A Pitino, S Squillaci, C Spairani, et al.
British Journal of Cancer
|
June 28, 2002
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL
G Cutrona, P Tasso, M Dono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy
F Ferrara, F Morabito, B Martino, et al.
Blood Cancer Journal
|
September 10, 2016
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome
D Ronchetti, M Manzoni, L Agnelli, et al.
Leukemia
|
February 5, 2015
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
F R Mauro, S Chauvie, F Paoloni, et al.
Cell Death & Disease
|
November 30, 2012
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N Amodio, M T Di Martino, U Foresta, et al.
Leukemia
|
November 14, 2013
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial
A Cortelezzi, M Sciumè, A M Liberati, et al.
Leukemia
|
January 6, 2017
Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy
G Cutrona, S Matis, M Colombo, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
ESMO Open
|
July 16, 2025
A network meta-analysis of randomized clinical trials in lenalidomide-exposed or -refractory multiple myeloma patients
E A Martino, G Caridà, D Lofaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 11, 2008
Bortezomib, doxorubicin and dexamethasone in advanced multiple myeloma
A Palumbo, F Gay, S Bringhen, et al.
Pathologica
|
March 8, 2012
Primary synovial sarcoma of the kidney. A case report with pathologic appraisal investigation and literature review
A Pitino, S Squillaci, C Spairani, et al.
British Journal of Cancer
|
June 28, 2002
CD10 is a marker for cycling cells with propensity to apoptosis in childhood ALL
G Cutrona, P Tasso, M Dono, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 15, 2000
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy
F Ferrara, F Morabito, B Martino, et al.
Blood Cancer Journal
|
September 10, 2016
lncRNA profiling in early-stage chronic lymphocytic leukemia identifies transcriptional fingerprints with relevance in clinical outcome
D Ronchetti, M Manzoni, L Agnelli, et al.
Leukemia
|
February 5, 2015
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
F R Mauro, S Chauvie, F Paoloni, et al.
Cell Death & Disease
|
November 30, 2012
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1
N Amodio, M T Di Martino, U Foresta, et al.
Leukemia
|
November 14, 2013
Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial
A Cortelezzi, M Sciumè, A M Liberati, et al.
Leukemia
|
January 6, 2017
Effects of miRNA-15 and miRNA-16 expression replacement in chronic lymphocytic leukemia: implication for therapy
G Cutrona, S Matis, M Colombo, et al.
Page
of 14